MedTech Dive February 23, 2024
Langoe, the former head of Palette Life Sciences, spoke about his plans to expand use of GT Medical’s cancer-fighting implant.
Per Langoe has started a new position as CEO of GT Medical Technologies, the company announced this week, replacing its founding CEO Matthew Likens.
Langoe was the co-founder and former CEO of Palette Life Sciences, which Teleflex acquired for $600 million in July 2023, and he will now lead GT Medical’s strategy to accelerate the adoption of its implantable treatment to eradicate brain tumor cells.
The company’s cancer-fighting treatment, called GammaTile, delivers radiation therapy within the cavity left in the brain after a tumor has been removed. The resorbable collagen tiles used to line the brain cavity are embedded with...
Today's Sponsors
Today's Sponsor